Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -418,780 | -296,799 | -248,655 | -167,250 | -554,128 |
| Depreciation Amortization | 37,915 | 27,872 | 17,377 | 8,930 | 26,911 |
| Accounts receivable | -51,650 | -48,447 | -26,180 | -16,863 | -10,461 |
| Other Working Capital | -98,166 | -144,061 | -27,115 | -57,287 | 554,056 |
| Other Operating Activity | 87,509 | 47,589 | -4,944 | 52,099 | 91,088 |
| Operating Cash Flow | $-443,172 | $-413,846 | $-289,517 | $-180,371 | $107,466 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 436,012 | 466,000 | 406,011 | 180,011 | -144,088 |
| PPE Investments | -38,490 | -36,284 | -27,043 | -21,149 | -82,202 |
| Purchase Of Investment | -1,800 | -29,988 | N/A | N/A | N/A |
| Purchase Sale Intangibles | 99,691 | 102,000 | 102,000 | N/A | 108,069 |
| Other Investing Activity | 99,691 | 98,262 | 98,757 | -2,196 | 104,569 |
| Investing Cash Flow | $495,413 | $497,990 | $477,725 | $156,666 | $-121,721 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 291,150 |
| Common Stock Issued | 569,334 | 18,654 | 12,752 | 9,226 | 396,010 |
| Other Financing Activity | -7,765 | -6,333 | -6,333 | -6,333 | -4,837 |
| Financing Cash Flow | $561,569 | $12,321 | $6,419 | $2,893 | $682,323 |
| Beginning Cash Position | 1,511,713 | 1,511,713 | 1,511,713 | 1,511,713 | 843,645 |
| End Cash Position | 2,125,523 | 1,608,178 | 1,706,340 | 1,490,901 | 1,511,713 |
| Net Cash Flow | $613,810 | $96,465 | $194,627 | $-20,812 | $668,068 |
| Free Cash Flow | |||||
| Operating Cash Flow | -443,172 | -413,846 | -289,517 | -180,371 | 107,466 |
| Capital Expenditure | -38,490 | -36,284 | -27,043 | -21,149 | -82,202 |
| Free Cash Flow | -481,662 | -450,130 | -316,560 | -201,520 | 25,264 |